Showing results (521-530 of 656) with videos related to
Sort By:
Pageof 66
The Journal of Biological Chemistry|November 5, 2003
Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic toleranceJay P McLaughlin, Lisa C Myers, Paul E Zarek, et al.The Journal of Biological Chemistry|December 25, 1989
The human 5-HT1A receptor expressed in HeLa cells stimulates sodium-dependent phosphate uptake via protein kinase CJ R Raymond, A Fargin, J P Middleton, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2J W Lomasney, W Lorenz, L F Allen, et al.Proceedings of the National Academy of Sciences of the United States of America|May 13, 2015
Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptorSean M Peterson, Thomas F Pack, Angela D Wilkins, et al.ACS Chemical Neuroscience|June 19, 2012
Optimizing the Temporal Resolution of Fast-Scan Cyclic VoltammetryBrian M Kile, Paul L Walsh, Zoé A McElligott, et al.Neuron|January 7, 2000
Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient miceR R Gainetdinov, L M Bohn, J K Walker, et al.The European Journal of Neuroscience|May 3, 2000
Increased rewarding properties of morphine in dopamine-transporter knockout miceC Spielewoy, F Gonon, C Roubert, et al.The Journal of Biological Chemistry|September 5, 1992
Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene familyH Attramadal, J L Arriza, C Aoki, et al.Neuroscience|March 7, 2006
Norepinephrine transporter-deficient mice respond to anxiety producing and fearful environments with bradycardia and hypotensionN R Keller, A Diedrich, M Appalsamy, et al.Journal of Neurochemistry|October 1, 1993
D1 dopamine receptor binding and mRNA levels are not altered after neonatal 6-hydroxydopamine treatment: evidence against dopamine-mediated induction of D1 dopamine receptors during postnatal developmentG E Duncan, G R Breese, H E Criswell, et al.Pageof 66